• English
  • Korean
  • Chinese
市場調査レポート - 236763

世界の遺伝子検査市場

Genetic Testing

発行 Global Industry Analysts, Inc.
出版日 ページ情報 英文 287 Pages
価格

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。 PDFのダウンロード・閲覧には Adobe Digital Editions が必要となります。ご購入頂いた場合、同Adobe Digital Editions (ご購入時無償配布)をPCにインストールして頂き、ダウンロードを行ったPC上のみでの閲覧と、1回のプリントアウトが可能となっております。ご不明な点につきましてはお問合せください。

世界の遺伝子検査市場 Genetic Testing
出版日: 2014年06月01日 ページ情報: 英文 287 Pages
概要

当レポートでは、世界の遺伝子検査市場について分析し、米国、カナダ、日本、欧州、アジア太平洋地域などの地域別の動向、今後の市場予測、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 世界市場概要
    • 幕開け
    • 主要な遺伝子疾患トップ10
    • 遺伝子検査:新たな時代の到来
    • 遺伝子検査が個別化医療の道を開く
    • 世界的人口増加が成長の機会を増大
    • 高齢人口が遺伝子検査市場を牽引
    • 医療費の改善が需要を拡大
    • 遺伝子検査:急速に開発される体外診断薬(IVD)市場の重要部分
    • 遺伝子検査:分子診断市場の急速な成長分野
    • バイオマーカー創薬が遺伝子検査の発展をリード
  • セグメント別レビュー
  • 市場動向
    • 消費者への直接遺伝子検査
    • 新規企業にとってのプラットフォームづくり
    • DTC遺伝子検査会社のビジネスモデル
    • DTC遺伝子検査の卓越さ
    • 着床前遺伝子診断
    • 全ゲノムシーケンシング
    • アルツハイマー用の新興の遺伝子検査の妥当性
    • ワーファリン研究のための遺伝子検査の利用
    • 癌:遺伝子検査の重要な注目分野
    • 中枢神経系治療を助ける遺伝子検査 他
  • 分子診断市場
  • 製品概要
    • 遺伝子検査の概要
    • 遺伝子検査とその応用
    • 遺伝子候補とゲノムスクリーン
    • 遺伝子における変化を特定するのに用いる技術
    • 遺伝子検査の種類
    • 遺伝子検査のリスクとその他の制限事項 他
  • 製品上市/技術革新
  • 近年の業界活動
  • 主要参入企業
    • Abbott Laboratories
    • Abbott Molecular, Inc.
    • AutoGenomics, Inc.
    • BioRad Laboratories
    • ELITech Group S.P.A.
    • PerkinElmer, Inc.
    • Quest Diagnostics, Inc.
    • Roche Diagnostics Corp
    • Roche Molecular Diagnostics, Inc.
    • Thermo Fisher Scientific
    • Transgenomic, Inc.
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • その他の諸国

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

This report analyzes the worldwide markets for Genetic Testing in US$ Million by the following Product Segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 73 companies including many key and niche players such as -

Abbott Laboratories
AutoGenomics, Inc.
BioRad Laboratories
ELITech Group S.P.A
PerkinElmer, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Prenatal Diagnosis and Newborn Genetic Testing
    • Pharmacogenetics/Pharmacogenomics
    • Predictive Testing

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW

  • A Curtain Raiser
  • Top Ten Genetic Disorders Worldwide
  • Genetic Testing: Heralding a New Era
  • Genetic Testing Paves the Way for Personalized Medicine
    • Table 1: Drug Ineffectiveness for Select Therapeutic Categories - Necessitating Personalized Medicine (includes corresponding Graph/Chart)
  • Ballooning Global Population Offers Increased Growth Opportunities
    • Table 2: Top 25 Countries Worldwide in Terms of Population: 2007, 2010 & 2013 (includes corresponding Graph/Chart)
  • Aging Population Drives the Genetic Testing Market
    • Table 3: Global Population Statistics for the 65+ Age Group (2012) (includes corresponding Graph/Chart)
    • Table 4: Elderly Population (65+ Years) as a % of Total Population (2025) (includes corresponding Graph/Chart)
  • Improving Healthcare Expenditure to Drive Demand
    • Table 5: Per-Capita Healthcare Expenditure in Select Regions: 2013 (includes corresponding Graph/Chart)
    • Table 6: Healthcare Spending as a Percentage of GDP: 2012 (includes corresponding Graph/Chart)
  • Genetic Testing - A Critical Part of the Rapidly Developing In-Vitro Diagnostics (IVD) Market
    • Table 7: Global In Vitro Diagnostics (IVD) Market by Geographic Region (2013): Percentage Share Breakdown of Revenues for the United States, Europe, and Rest of World (includes corresponding Graph/Chart)
    • Table 8: Global In-Vitro Diagnostics Market by Sector (2013): Percentage Breakdown of Revenues for Hospital & Commercial Laboratories, and Decentralized & Patient Self-Testing (includes corresponding Graph/Chart)
    • Table 9: Global In-Vitro Diagnostics Market by Segment (2013): Percentage Breakdown of Value Sales for Hematology, Hemostasis, Immunochemistry, Microbiology, Molecular Diagnostics, Point-of-Care Diagnostics, Self-Monitoring Blood Glucose, and Tissue Diagnostics (includes corresponding Graph/Chart)
    • Table 10: Global In Vitro Diagnostics Market by Leading Player (2013): Percentage Share Breakdown of Revenues for Abbott, Biomerieux, Danaher, J&J, Roche, Siemens and Others (includes corresponding Graph/Chart)
  • Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market
    • Table 11: Global Molecular Diagnostics Market (2013): Percentage Breakdown of Market Revenues of Infectious Disease Testing, Genomics, and Blood Donor Screening (includes corresponding Graph/Chart)
  • Biomarker Discovery Leads to Advanced Genetic Testing
    • List of US-FDA Approved Biomarkers for Cancer

2. SEGMENTAL REVIEW

  • Prenatal Testing Market to Rise
  • List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
  • Prenatal Testing - Changing the World of Pregnancy Care
  • Prenatal Testing - A Rudimentary Overview
    • List of Available Prenatal Screening and Diagnostic Tests by Indication
  • Conventional Pre-Natal Diagnostic Techniques - A Risky Affair
  • Other Negativities of Existing Invasive Techniques
  • Emergence of Non-Invasive Prenatal Diagnosis (NIPD)
    • Competition Intensifies in the NIPD Market
      • Commercially Available NIPD (Genetic) Tests for Aneuploidy in the US
    • NIPD Eliminates Risks and Uncertainty of Conventional Diagnostic Procedures
    • Opposition to NIPD Technique - A Significant Hurdle to Adoption
    • Ethical Issues Bog Down Benefits and Proliferation of Prenatal Testing
    • Benefits Outweigh Snags in NIPD Tests
    • Major Factors Influencing Penetration of NIPD Tests
    • Table 12: Price Comparison of Existing Tests and Screening Procedures for Down's syndrome
    • Diversity in NIPD Usage on the Cards
  • Expanded Newborn Screening
  • Predictive Diagnostics
  • Breast Cancer Gene Testing Market to Expand Strongly
  • Myriad Genetics - The Unquestioned Leader in Breast Cancer Testing
  • Routine Clinical Testing Vs. Predictive Genetic Testing
  • Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
  • Discovery of Novel Biomarkers Crucial to Predictive Diagnostics
  • Unresolved Issues Hamper Widespread Implementation of Genetic Diagnosis and Testing for Monogenetic Disease
  • Dearth of Genetic Counselors - A Major Hurdle for the Predictive Genetic Testing
  • Pharmacogenomics Development Augurs Growth of Genetic Testing Market

3. MARKET TRENDS

  • Direct-to-Consumer Genetic Testing - A Key Trend in the Genetic Testing Market
  • Creating a Platform for New Companies
  • Business Models for DTC Genetic Testing Firms
  • Growing Prominence of DTC Genetic Testing: A Boon or a Curse?
  • Pre-implantation Genetic Diagnosis (PGD) - A Major Driver for the Genetic Testing Market
  • Whole Genome Sequencing - Boon or Bane to Genetic Testing?
  • Validity of Emerging Genetic Tests for Alzheimer's
  • Utility of Genetic Testing for Warfarin Study
  • Oncology - A Key Focus Area for Genetic Testing
    • Table 13: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 14: New Cancer Cases in the World by Affected Site (2012) (in Thousands) (includes corresponding Graph/Chart)
    • Table 15: Cancer Incidence in Developed Nations by Site: 2012 (includes corresponding Graph/Chart)
    • Table 16: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart)
    • Table 17: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart)
    • Table 18: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)
  • Genetic Testing May Aid CNS Disease Therapeutics
  • Neurodegenerative Diseases - Major Focus Area for Genetic Testing
  • Alzheimer's Disease
  • Huntington's Disease
  • Genetic Testing - An Indispensible Tool for Cystic Fibrosis
    • Table 19: Most Common Mutations and Worldwide Frequency (includes corresponding Graph/Chart)
  • Histocompatibility Testing
    • Table 20: Global HLA Testing Market (2012-2016E): Revenue Estimates for 2012, 2013, 2014, 2015, and 2016 (includes corresponding Graph/Chart)
  • Next-Generation Sequencing - A Giant Leap in Genome Sequencing
  • Pediatric Genetic Testing for Screening Adult Onset Disorders Fast Gaining Acceptance
  • Better Regulatory Safeguards Required for Global Genetic Testing Industry
  • Challenges Faced
  • Genetic Counseling: Gaining Momentum
  • Online Approach Gains Momentum
  • Recommendations of ACOG and ACGM Augments Demand for Cystic Fibrosis Testing
  • Ethical Issues & Need for Appropriate Regulating Policies
  • Issues Related to Genetic Tests for Obesity
  • Diagnosis and Treatment during Pregnancy - An Effective Way of Alleviating Syphilis Related Deaths and Stillbirths

4. MOLECULAR DIAGNOSTICS MARKET - AN INSIGHT

  • Global Molecular Diagnostics on a High Growth Curve
  • Automation Driving Global Market
  • Molecular Diagnostics: Marking the Convergence of Numerous Technologies
  • MDx Market for Infectious Diseases Zooming Ahead
  • Aging Population, Disease Incidence - Fundamental Drivers of Growth
  • Pharmaceutical Firms Carving Their Niche in Molecular Diagnostics Market
  • Towards Tailoring the Right Treatment for the Right Disease
  • Limited Reimbursements by Third Party Payers - A Stumbling Block
  • Disease-Specific Molecular Diagnostics to Deliver Improved Clinical Outcomes
  • Molecular Diagnostics and Intellectual Property
  • Business Opportunities in the Offing
  • Medical Training and Practice Challenges
  • Hurdles All the Way for Companies Eyeing Molecular Diagnostics
  • Product Marketing - Key to Commercial Success
  • Integration of Molecular Diagnostics into Therapeutics
  • Molecular Diagnostics - Moving from Centralization to Decentralization
  • Migrating to Decentralized Format
  • Going Ahead with Decentralization
  • Competitive Landscape of the Molecular Diagnostics Market
    • Table 21: Global Molecular Diagnostics Market by Leading Players (2012): Market Share Breakdown for Abbott, BD, Cepheid, Hologic Gen-Probe, Novartis Dx, Qiagen, Roche, Siemens Dx, and Others (includes corresponding Graph/Chart)
  • New Entrants Eye Unmet Needs

5. PRODUCT OVERVIEW

  • Preface to Genetic Testing
  • Genetic Testing and its Applications
  • Gene Candidate and Genome Screen
  • 'DNA Chip' to Chip into Genetic Field
  • Techniques Used to Identify Changes in Genes
  • Types of Genetic Testing
  • Prenatal Diagnosis
    • Cancer Testing
    • Carrier Identification
  • Newborn Screening
  • Predictive Testing
  • Pre-Symptomatic Testing
  • Cytogenetic Tests
  • Steps in Genetic Testing Process
  • Limitations
  • Risks and Other Limitations of Genetic Testing
  • Medical Institutions to Reap the Benefit of Genetic Testing
  • Pharmacogenetics/Pharmacogenomics
  • Review of Select Genetic Tests
  • Cystic Fibrosis
  • Breast and Ovarian Cancer (BRCA)
  • Alzheimer's Disease
  • Colorectal Cancer
  • Haemochromatosis (HH)
  • Cowden Syndrome
  • Huntington's Disease (HD)
  • Costs of Select Tests
    • Table 22: Costs of Select Genetic Tests
  • GENETIC TESTING TECHNIQUES
  • Signal Amplification Technologies
    • PCR - New Developments
    • Quantitative Real-Time PCR for Molecular Diagnostics
    • Signal Detection and Quantification
    • Quantitative Real-Time RT-PCR Analysis
  • Applications of Quantitative Real-Time PCR Analysis
    • Viral Detection and Viral-Load Monitoring
    • Sensitive Detection of Infectious Disease Agents
    • Predisposition Testing
  • Non-PCR Methods
  • Other Signal Amplification Technologies
  • DNA Probe Based Products
  • Direct Detection of Specific Nucleic Acid Sequences
  • Nucleic Acid Amplification and Detection
  • DNA Sequencing and Gene Detection
  • Arrays of Immobilized Probes (DNA Chips) in Gene Detection
  • RNA Diagnostics

6. PRODUCT LAUNCHES/INNOVATIONS

  • Courtagen Launches Genetic Sequencing Tests for Neurodevelopmental Disorders
  • Myriad Genetics Launches EndoPredict(r) Breast Cancer Test
  • Assurex Health Expands GeneSight(r) Pharmacogenomic Testing Platform
  • Illumina to Launch VeriSeq Embryo Screening Tool
  • GENEWIZ Launches PGxOne(tm) Pharmacogenomic Test
  • Ambry Genetics Launches ExomeNext(tm) and ExomeNext-Rapid(tm) Genetic Tests
  • Pathway Genomics Launches Genetic Test to Detect Risk of Colorectal Cancer
  • Mount Sinai Laboratory Develops Accurate Genetic Test for SMA
  • Sequenom Launches Non-Invasive Prenatal Test by Laboratoire Cerba
  • CSL Behring Launches Antitrypsin Deficiency Screening Test
  • Interleukin Genetics Launches PerioPredict(tm)
  • US Genomic Health Reports Positive Data from Oncotype DX Prostate Cancer Study
  • Assurex Health Launches GeneSight Test to Predict Folic Acid Conversion and Treat Depression
  • Verifi (r) Prenatal Test Available Through California Prenatal Screening Program
  • Children's Mercy Launches TaGSCAN Test
  • General Genetics and Estrogen Gene Test Launch EstroGene(tm) Test
  • Genetic Analysis Launches GA-map(tm) Test
  • Myriad Genetics Launches myRisk(tm) Hereditary Cancer Test
  • GeneDx Launches Genetic Tests for Cancer
  • ArcticDx Launches Vita Risk Pharmacogenetic Test for AMD Patients
  • Quest Diagnostics Launches CYP450 Biomarker-based Diagnostic Test
  • Blueprint Genetics Launches Gene Sequencing Tests
  • Bioiberica Farma Launches Genetic Test for Osteoarthritis
  • Illumina, The Wellcome Trust Centre and the Institute of Cancer Research Roll out Genetic Test
  • Aviir to Launch Genetic Testing for Inherited Cardiovascular Disease
  • Oxford University Hospitals Launches 46-gene Sequencing Test for Cancer
  • Millennium Labs Launches Millennium PGT Testing
  • NutraGene Unveils Genetic Testing for Type2 Diabetes
  • IntegraGen Unveils ARISk(tm) Test for Autism

7. RECENT INDUSTRY ACTIVITY

  • Cancer Genetics Acquires BioServe Biotechnologies
  • PerkinElmer to Close Its Signature Genomics Testing Business
  • LifeLabs Medical Laboratory Services Buys out Centogene's Canadian Business
  • CytoScan Dx Assay by Affymetrix Receives FDA Approval
  • Sequenom and CombiMatrix Enter Marketing Agreement for Chromosomal Microarray Analysis
  • Illumina Acquires Verinata Health
  • Gene Security Network Changes Name to Natera
  • TrovaGene Acquires MultiGEN Diagnostics
  • Adaptive TCR Corp. is now Adaptive Biotechnologies
  • TrovaGene Acquires Exclusive License on SF3B1 Mutations

8. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories (US)
  • Abbott Molecular, Inc. (US)
  • AutoGenomics, Inc. (US)
  • BioRad Laboratories (US)
  • ELITech Group S.P.A. (France)
  • PerkinElmer, Inc. (US)
  • Quest Diagnostics, Inc. (US)
  • Roche Diagnostics Corp. (Switzerland)
  • Roche Molecular Diagnostics, Inc. (US)
  • Thermo Fisher Scientific (US)
  • Transgenomic, Inc. (US)

9. GLOBAL MARKET PERSPECTIVE

    • Table 23: World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for Genetic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 25: World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • The US: Leading Market for Genetic Testing Globally
    • Demographic Changes Offer Growth Opportunities
    • Table 26: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Burgeoning Potential for Genetic Testing
    • Predictive Screening: Another Growth Area
    • An important Market for Personalized Medicine
    • Epidemic Proportion of Cancer in the US - Driver for Cancer Genetic Testing
    • Table 27: New Cancer Cases by Gender and Affected Site in the US (2013) (includes corresponding Graph/Chart)
    • Newborn Testing Gains Ground
      • Success Stories
    • Favorable Reimbursement Policies
    • Favorable Insurance Coverage for Cystic Fibrosis Genetic Testing
    • Table 28: CF Carrier Screening: Percentage Breakdown of Population by Coverage Policy: 2012 (includes corresponding Graph/Chart)
    • Table 29: CF Diagnostic Testing: Percentage Breakdown of Population by Coverage Policy: 2012 (includes corresponding Graph/Chart)
    • Popularity of Screening and ACOG Guidelines Sink Invasive Prenatal Diagnosis Numbers
    • Table 30: US Annual Pregnancies by Age Group/Risk Profile: 2010 (includes corresponding Graph/Chart)
    • Tough Market Prospects for Sex Determination Tests
    • Sequenom Bets Big on MaterniT21
    • IP Landscape of NIPD Tests
    • Table 31: List of Number of Patents Held by Companies/Institutions Offering NIPT: 2012 (includes corresponding Graph/Chart)
    • US Patents of cff DNA-based NIPD Tests
    • Direct-to-Consumer Testing - A Growing Market
      • DTC Genetic Tests Provide POCT for Patients in Hospice Care
    • Regulatory Environment
      • Genetic Information Nondiscrimination Act Boosts Genetic Testing
      • NIH Launches Public Database
      • Stricter Regulations for DTC Genetic Testing
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 32: The US Recent Past, Current & Future Analysis for Genetic Testing by Segment - Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 33: The US Historic Review for Genetic Testing by Segment - Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 34: The US 15-Year Perspective for Genetic Testing by Segment - Percentage Breakdown of Dollar Sales for Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Medicine Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Rising Incidence of Chronic Diseases Spurs Genetic Testing Demand
    • Table 35: New Cancer Cases in Canada by Gender and Affected Site: 2012 (includes corresponding Graph/Chart)
    • Table 36: New Cancer Cases in Canada by Province: 2012 (includes corresponding Graph/Chart)
    • Table 37: New Cancer Cases in Canada by Age Group and Gender: 2012 (includes corresponding Graph/Chart)
    • Product Launch
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 38: Canadian Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 39: Canadian Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Demographics Drive Market Growth
    • Table 40: Percentage Breakdown of Japanese Population by Age Group (2012) (includes corresponding Graph/Chart)
    • Table 41: Japanese 65+ Years Population: 1950-2010 (includes corresponding Graph/Chart)
    • DTC Genetic Testing Regulatory Scenario
  • B. Market Analytics
    • Table 42: Japanese Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 43: Japanese Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Debt Crisis in Europe Affects Healthcare Industry
    • European Healthcare System: In a State of Transition?
    • An Insight into Molecular Diagnostics Markets in Europe
    • Cancer Trends
    • Table 44: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Aging Population to Drive Demand for Genetic Testing
    • Table 45: Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart)
    • European Personalized Medicine Market to Exhibit Robust Growth
    • Legislations/Regulatory Policies in Select European Countries
    • Legislations Governing Genetic Testing in Select European Countries
  • B. Market Analytics
    • Table 46: European Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 47: European Historic Review for Genetic Testing by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 48: European 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Regulatory Environment in France
    • Product Launch
    • ELITech Group s.p.a. - A Key Player
  • B. Market Analytics
    • Table 49: French Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 50: French Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Parliamentary Regulations
  • B. Market Analytics
    • Table 51: German Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 52: German Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 53: Italian Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 54: Italian Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Increased Support for Personalized Medicine to Drive Genetic Testing
    • SMIP for Pharmacogenomic Testing
    • Increasing Need for Less Risky Prenatal Diagnostic Methods in the UK
    • Regulatory Scenario
      • Non-consensual Analysis of DNA Made Illegal
      • Principles for DTC Genetic Testing Laid out by HGC
    • Product launches
  • B. Market Analytics
    • Table 55: The UK Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 56: The UK Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

4e. REST OF EUROPE

  • A. Market Analysis
    • Product Launches
    • Roche Diagnostics Corp. - A Key Player (Switzerland)
  • B. Market Analytics
    • Table 57: Rest of European Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 58: Rest of European Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Healthcare Spending in Asia-Pacific: On the Rise
    • Select Regional Markets
      • China
      • China's FDA Curbs Prenatal Testing
    • Table 59: China - The Most Populous Country Worldwide (July 2013): Total Population (in Millions) by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China Vis-a-Vis Other Countries (includes corresponding Graph/Chart)
    • Table 60: China - The Most Populous Country Worldwide (July 2013): Percentage Population by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China Vis-a-Vis Other Countries (includes corresponding Graph/Chart)
      • Diagnostics Market in India
      • Australia and New Zealand
      • Approval of Experiments on Human Embryos in New Zealand
      • Singapore Sets Guidelines for Genetic Research and Testing
    • Product Launch
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 61: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 62: Asia-Pacific Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • Market Analysis
    • Table 63: Rest of World Recent Past, Current & Future Analysis for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 64: Rest of World Historic Review for Genetic Testing Market Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Back to Top